Orthovita, Inc. Reports 2006 Second Quarter Financial Results; Second Quarter 2006 Sales Of $11.2 Million Reflect 32% Growth Over Second Quarter 2005; Year-To-Date June 30, 2006 Sales Of $22.0 Million Reflect 34% Growth Over Same Period 2005

Orthovita, Inc. (NASDAQ:VITA), a developer of orthopedic biomaterials, reported financial results for the three and six months ended June 30, 2006. Product sales for the three months ended June 30, 2006 increased 32% to $11,180,000, as compared to $8,470,000 for the same period in 2005. Product sales for the six months ended June 30, 2006 increased 34% to $21,997,000, as compared to $16,356,000 for the same period in 2005. Sales growth for the reported periods was primarily attributable to increased sales of our VITOSS(R) FOAM and VITAGEL(TM) product portfolios in the U.S. as we further develop our U.S. field sales network.